Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera June 11, 2026 New analyses from the Phase 1 SANRECO study demonstrate potential improvements in PV symptoms and quality-of-life Follow-up data show substantial reductions in phlebotomy use persisting after final dose Phase 2 SANRECO study evaluating Q6W and Q12W dosing remains on-track for topline results in August 2026
Harley Street Health District Releases First Annual Impact Report June 11, 2026 New report demonstrates annual market value of Harley Street Health District is £1.85 billion, approximately £143 million growth in 12 months Estimated annual contribution to the UK economy is £810 million, predicted to reach £911 million in the next year Investment in HealthTech property in the District last year totalled £42.4 million from The Howard de Walden Estate
Northern Trust Asset Management Launches Sustainable Multifactor Funds June 11, 2026 UCITS Funds Provide Climate Focused Core Equities Strategies
Comrade Trustee Services goes live with Smartstream’s Air, the AI reconciliation and data automation solution June 11, 2026 Key Facts Comrade Trustee Services is live on Smartstream’s Air for automated reconciliations with fully integrated workflows. The implementation replaces highly manual, spreadsheet-driven processes and complex file handling with a single-click, straight-through AI-driven workflow. This will improve accuracy, control and operational efficiency. Processing time has been reduced from up to eight hours to under five minutes, with additional scalability for complex file types, formats and reconciliation logic.
Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer June 11, 2026 Anocca AB (‘Anocca’ or the ‘Company’), a clinical-stage biotechnology company developing advanced T-cell immunotherapies, today announced the successful dosing of the first patients across multiple clinical sites with ANOC-001, a novel T cell receptor-modified T cell therapy (TCR-T)[1] targeting KRAS G12V mutations in an aggressive form of pancreatic cancer. ANOC-001 is the first product to [...]
Dole Expands Year Two of Highly Successful Global Campaign With Minecraft Designed Towards Maximum Performance With New Pineapple-Focused Experience June 11, 2026 Nutrition, hydration and energizing recipes among tips for peak gameplay
Abbove strengthens its banking position with the deployment of its platform at ING in Belgium June 11, 2026 Belgian WealthTech Abbove announces the deployment of its wealth planning platform at ING Belgium. The bank is making a new digital wealth planning experience, ING Financial Compass, available to its Personal Banking and Private Banking clients, built on Abbove technology and specially adapted to its advisory model. This press release features multimedia. View the full [...]
Baghdadi Capital integrates Qasioun Partners, Strengthening Its Financial Advisory Proposition June 10, 2026 Baghdadi Capital, a global independent family office specialising in corporate and investment banking, announces the integration of Qasioun Partners, a new firm specialising in Advisory Finance and Investment Banking, which joins the Group with its own capital structure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260610028423/en/ Qasioun Partners originated from the advisory [...]
Fideres Study Finds TfL Fare Zones Disproportionately Burden Ethnic Minority Commuters June 10, 2026 London's Underground fare zone system may constitute unlawful indirect discrimination against BAME commuters, according to a new study by Fideres Partners.
BTG Pactual TIG Acquires Jamestown’s Timberland Platform June 10, 2026 Acquisition includes approximately 90,000-acre U.S. timberland portfolio